It’s #WorldHepatitisDay. A person dying every 30 seconds from a hepatitis-related illness is an ongoing emergency. It’s vital we accelerate the fight against viral hepatitis, just as Prof. Sharon Lewin—head of Melbourne’s @TheDohertyInst— is doing.
At the White House with our #WorldHepatitisDay messages:
What are you waiting for?
300M reasons to end #HepB
We are fighting for our lives
We need access to treatment now!
Tick Tock, Time is up
Simplify #HepB Guidelines
The longer you wait, the earlier our fate!
#NotWaiting
Congratulations to Dr Loey Lung-Yi Mak from Hong Kong on receiving the EASL 2023 Emerging Leader award at the Liver Congress here in Vienna. A fantastic achievement from an inspiring clinician scientist and hepatitis virus researcher!!
Hepatitis Australia welcomes @hepbvoices_au - the first hepatitis B community-led organization that is wholly led by people affected by hepatitis B in Australia.
We can’t wait to work together to get action and investment on Hepatitis B!
https://t.co/jVPInzgBP6
Congratulations to @TheRMH and @TheDohertyInst's Prof @PeterRevill1, who today received more than $1.4M from @nhmrc. The funds will go toward his research into novel therapeutics for Hepatitis B. Read more about Peter's work on @TheDohertyInst website: https://t.co/jnMWJ0U5FO
Delighted to have received an NHMRC ideas grant to pursue our HBV curative research. An amazing team effort building on years of collaborative research and I can’t wait to get cracking on this project!!
Most people with #hepatitisB don’t look sick, so how do you fight an invisible disease?
You fund programs like screening, linkage to care, and advocacy, that shed light on this life-threatening disease that affects millions of people.
Donate today:
https://t.co/WQeSrHIFBm
Awesome post-doc job opp with Prof Jose Villadangos @TheDohertyInst @UniMelbMDHS Check it out.....Research Officer/Senior Research Officer in Immunology/Biochemistry/Cell Biology https://t.co/YwB4IDqqjQ
World first study of #hepatitisB virus using deep sequencing shows less diverse #HBV genomes more likely to respond to treatment, increasing likelihood of patients achieving functional cure. https://t.co/0mgOfuXB82
@PeterRevill1@TheRMH @UniMelbMDHS
Thrilled to see the Cumming Global Centre for Pandemic Therapeutics featured in @theage 52 News Makers for 2022! https://t.co/ey6LTttayz
@UniMelb @UniMelbMDHS @TheRMH@ProfSharonLewin
Congratulations to our Scientific Advisory Board member, Nobel Laureate Prof Françoise Barré-Sinoussi for being conferred with an honorary doctorate by @UniMelb, recognised for her lifetime contributions to #HIVcure and AIDS research https://t.co/BTnhh0xHCm
@UniMelbMDHS @TheRMH
Delighted our Hepatitis B Virus serum biomarkers review is featured on the cover of the November issue of Nature Reviews Gastroenterology and Hepatology- a truly global collaborative effort led by ICE-HBV https://t.co/cO62OERAPJ @ICE_HBV@TheDohertyInst
Excited to finally tweet about the launch of Computational Sciences Initiative at @TheDohertyInst , supported by J & M Wright Foundation. CSI focuses on computational approaches in 3 aspects of infectious disease: Discovery Research, Public Health, and Clinical and Health Systems
Great to see this ⬇️as #HBV has lived in hepatitis C's shadow for too long.
More education = better advocacy = more positive change!
@HepBFoundation@ICE_HBV@thatliverguy @OzCapucine @NO_hep